HRP20080686T3 - Method of purifying pravastatin - Google Patents
Method of purifying pravastatinInfo
- Publication number
- HRP20080686T3 HRP20080686T3 HR20080686T HRP20080686T HRP20080686T3 HR P20080686 T3 HRP20080686 T3 HR P20080686T3 HR 20080686 T HR20080686 T HR 20080686T HR P20080686 T HRP20080686 T HR P20080686T HR P20080686 T3 HRP20080686 T3 HR P20080686T3
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- pravastatin
- compactin
- hydroxy
- containing less
- Prior art date
Links
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 title abstract 3
- 229960002965 pravastatin Drugs 0.000 title abstract 3
- VGMFHMLQOYWYHN-UHFFFAOYSA-N Compactin Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)c4C(=O)C(=COc4c3)c5ccc(O)c(O)c5)C(O)C(O)C1O VGMFHMLQOYWYHN-UHFFFAOYSA-N 0.000 abstract 2
- AJLFOPYRIVGYMJ-UHFFFAOYSA-N SJ000287055 Natural products C12C(OC(=O)C(C)CC)CCC=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 AJLFOPYRIVGYMJ-UHFFFAOYSA-N 0.000 abstract 2
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 abstract 2
- BOZILQFLQYBIIY-UHFFFAOYSA-N mevastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CCC=C21 BOZILQFLQYBIIY-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- -1 2-methyl-1,2,3,7,8,8a-hexahydro-7-methyl-8- [2- (tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl) ethyl] - 1-naphthalenyl Chemical group 0.000 abstract 1
- 150000002969 pentanoic acid esters Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/48—Separation; Purification; Stabilisation; Use of additives
- C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52549403P | 2003-11-24 | 2003-11-24 | |
| US53231403P | 2003-12-22 | 2003-12-22 | |
| US55416504P | 2004-03-18 | 2004-03-18 | |
| PCT/US2004/039217 WO2005051372A2 (en) | 2003-11-24 | 2004-11-23 | Method of purifying pravastatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20080686T3 true HRP20080686T3 (en) | 2009-03-31 |
Family
ID=34637188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080686T HRP20080686T3 (en) | 2003-11-24 | 2008-12-30 | Method of purifying pravastatin |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7425644B2 (xx) |
| EP (2) | EP1641447B1 (xx) |
| JP (2) | JP2007512366A (xx) |
| AT (1) | ATE412409T1 (xx) |
| CA (1) | CA2546377A1 (xx) |
| DE (3) | DE04811862T1 (xx) |
| ES (1) | ES2251894T3 (xx) |
| HR (1) | HRP20080686T3 (xx) |
| PL (1) | PL1641447T3 (xx) |
| PT (1) | PT1641447E (xx) |
| TW (1) | TWI319707B (xx) |
| WO (1) | WO2005051372A2 (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005121062A2 (en) * | 2004-06-09 | 2005-12-22 | Ranbaxy Laboratories Limited | Process for the preparation of pravastatin |
| JP4775727B1 (ja) * | 2010-08-17 | 2011-09-21 | 貞宏 平山 | 印刷物の微小マークによる一般人が容易にできる真贋判定方法 |
| JP6218287B2 (ja) * | 2013-01-29 | 2017-10-25 | 学校法人産業医科大学 | シスプラチン耐性がんの治療のためのＨＭＧ−ＣｏＡ還元酵素阻害薬の使用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4319039A (en) | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
| US4346277A (en) * | 1979-10-29 | 1982-08-24 | Eaton Corporation | Packaged electrical heating element |
| DK149080C (da) | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
| DE3682557D1 (de) | 1985-09-13 | 1992-01-02 | Sankyo Co | Hydroxy-ml-236b-derivate, deren herstellung und anwendung. |
| US4857547A (en) | 1988-01-07 | 1989-08-15 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
| US4857522A (en) | 1988-03-21 | 1989-08-15 | E. R. Squibb & Sons, Inc. | Derivatives of pravastatin for inhibiting cholesterol biosynthesis |
| US5180589A (en) | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
| US5099035A (en) | 1989-02-27 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| US5140012A (en) | 1990-05-31 | 1992-08-18 | E. R. Squibb & Sons, Inc. | Method for preventing onset of restenosis after angioplasty employing pravastatin |
| US5202029A (en) | 1991-03-13 | 1993-04-13 | Caron Kabushiki Kaisha | Process for purification of hmg-coa reductase inhibitors |
| US5157025A (en) | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
| CZ292612B6 (cs) | 1992-05-20 | 2003-11-12 | Abbott Gmbh & Co. Kg | Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu |
| NZ250609A (en) | 1992-12-28 | 1995-07-26 | Sankyo Co | Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments |
| SI9300303A (en) | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
| IL112639A0 (en) | 1994-03-11 | 1995-05-26 | Bristol Myers Squibb Co | A pharmaceutical composition containing pravastin |
| US5616595A (en) | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Process for recovering water insoluble compounds from a fermentation broth |
| US5942423A (en) | 1995-06-07 | 1999-08-24 | Massachusetts Institute Of Technology | Conversion of compactin to pravastatin by actinomadura |
| ATE189804T1 (de) | 1995-08-03 | 2000-03-15 | Dsm Nv | Selektives verfahren zur deacylierung von acylverbindungen |
| US5883109A (en) | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
| US6165757A (en) | 1997-02-20 | 2000-12-26 | Dsm N.V. | Nitrogen feed in statin fermentation |
| KR100210482B1 (ko) | 1997-04-10 | 1999-07-15 | 김종인 | 스트렙토마이세스엑스포리아투스(streptomycesexfoliatus)yj-118과이를이용한프라바스타틴나트륨의제조방법 |
| AU9264598A (en) | 1997-08-22 | 1999-03-16 | Gist-Brocades B.V. | Statin production by fermentation |
| SI9800046A (sl) | 1998-02-18 | 1999-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti |
| JP2931971B1 (ja) | 1998-02-23 | 1999-08-09 | 利夫 佐藤 | プラバスタチンの製造法 |
| SI20072A (sl) | 1998-09-18 | 2000-04-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze |
| SI20305A (sl) | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
| CZ20012761A3 (cs) | 1999-02-03 | 2002-05-15 | Institute For Drug Research Ltd. | Mikrobiální způsob výroby pravastatinu |
| US6682913B1 (en) | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
| HUP9902352A1 (hu) | 1999-07-12 | 2000-09-28 | Gyógyszerkutató Intézet Kft. | Eljárás pravasztatin mikrobiológiai előállítására |
| DE60031447T2 (de) * | 1999-11-30 | 2007-08-30 | Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag | Verfahren zur rückgewinnung von statinverbindungen aus einer fermentationsbrühe |
| WO2001081611A1 (en) | 2000-04-27 | 2001-11-01 | Biocon India Limited | A novel process for the manufacture and purification of compactin |
| SK5232003A3 (en) * | 2000-10-05 | 2004-06-08 | Biogal Gyogyszergyar | Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
| JP3463881B2 (ja) * | 2002-08-06 | 2003-11-05 | 三共株式会社 | プラバスタチン又はその薬理上許容される塩の単離・精製方法 |
| TW589178B (en) * | 2003-02-21 | 2004-06-01 | China Chemical & Pharmaceutica | A novel industrial process to obtain pravastatin sodium of high purity |
-
2004
- 2004-11-23 WO PCT/US2004/039217 patent/WO2005051372A2/en not_active Application Discontinuation
- 2004-11-23 CA CA002546377A patent/CA2546377A1/en not_active Abandoned
- 2004-11-23 EP EP04811862A patent/EP1641447B1/en active Active
- 2004-11-23 PL PL04811862T patent/PL1641447T3/pl unknown
- 2004-11-23 US US10/996,238 patent/US7425644B2/en not_active Expired - Fee Related
- 2004-11-23 PT PT04811862T patent/PT1641447E/pt unknown
- 2004-11-23 DE DE04811862T patent/DE04811862T1/de active Pending
- 2004-11-23 DE DE602004017461T patent/DE602004017461D1/de active Active
- 2004-11-23 AT AT04811862T patent/ATE412409T1/de active
- 2004-11-23 DE DE202004020671U patent/DE202004020671U1/de not_active Expired - Lifetime
- 2004-11-23 JP JP2006541621A patent/JP2007512366A/ja active Pending
- 2004-11-23 ES ES04811862T patent/ES2251894T3/es active Active
- 2004-11-23 TW TW093135997A patent/TWI319707B/zh not_active IP Right Cessation
- 2004-11-23 EP EP08018298A patent/EP2033636A1/en not_active Withdrawn
-
2008
- 2008-08-07 US US12/187,555 patent/US20080300305A1/en not_active Abandoned
- 2008-12-30 HR HR20080686T patent/HRP20080686T3/xx unknown
-
2009
- 2009-02-04 JP JP2009024212A patent/JP2009161542A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL1641447T3 (pl) | 2009-04-30 |
| DE04811862T1 (de) | 2006-03-02 |
| CA2546377A1 (en) | 2005-06-09 |
| ATE412409T1 (de) | 2008-11-15 |
| WO2005051372A2 (en) | 2005-06-09 |
| TWI319707B (en) | 2010-01-21 |
| EP1641447A2 (en) | 2006-04-05 |
| DE202004020671U1 (de) | 2005-12-08 |
| ES2251894T3 (es) | 2009-04-01 |
| TW200518745A (en) | 2005-06-16 |
| JP2007512366A (ja) | 2007-05-17 |
| JP2009161542A (ja) | 2009-07-23 |
| ES2251894T1 (es) | 2006-05-16 |
| US20050113446A1 (en) | 2005-05-26 |
| WO2005051372A3 (en) | 2005-08-11 |
| PT1641447E (pt) | 2008-12-10 |
| DE602004017461D1 (de) | 2008-12-11 |
| EP1641447B1 (en) | 2008-10-29 |
| US7425644B2 (en) | 2008-09-16 |
| US20080300305A1 (en) | 2008-12-04 |
| EP2033636A1 (en) | 2009-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE380020T1 (de) | Stabile arzneiformulierungen enthaltend pravastatin or atorvastatin | |
| IL187261A0 (en) | Crystals of the sodium salt of pravastatin | |
| IS5891A (is) | Ný sölt HMG-CoA redúktasatálma | |
| WO2002036534A3 (en) | Processes for preparing linear polyglycerols and polyglycerol esters | |
| ATE260101T1 (de) | Stabilisierte pharmazeutisch wirksame zubereitung und diese enthaltende arzneizusammensetzung | |
| PE20020340A1 (es) | Composicion farmaceutica que comprende ester etilico de acido [2r,4s]-4-[(3,5-bis-trifluorometilbencil)metoxicarbonilamino]-2-etil-6-trifluorometil-3,4-dihidro-2h-quinolina-1-carboxilico y atorvastatina o sus metabolitos hidroxilicos | |
| ZA200603970B (en) | Process for the production of metal salts of trifluoromethane sulphonic acid and their use as esterification catalysts | |
| CO4810331A1 (es) | Proceso para la preparacion de esteres en presencia de un catalizador | |
| HRP20080686T3 (en) | Method of purifying pravastatin | |
| IS5886A (is) | Aðferð til að öðlast mjög hreina HMG-CoA redúktasahemla | |
| WO2003082799A3 (de) | Alicyclische ester mit moschusgeruch | |
| AU2000250960A1 (en) | Stable pharmaceutical product and formulation | |
| DE60204681D1 (de) | Verfahren zur herstellung von 2-[4-(2,2,-dihalocyclopropyl)phenoxy]-alkansäuren und ihre estern | |
| WO2001044144A3 (en) | Process for the preparation of sodium salts of statins | |
| PL367885A1 (en) | Methyl analogs of simvastatin as novel hmg-coa reductase inhibitors | |
| AU2003272077A1 (en) | Alpha-amino acid benzothiazolylthio ester as intermediates for manufacture of ace inhibitors and process for preparation thereof | |
| AR008486A1 (es) | Nuevas heteroariloxietilaminas, procedimiento para su fabricacion, medicamentos y composiciones farmaceuticas que las contienen, su uso y nuevosproductos industriales utilizados en dicho procedimiento. | |
| ATE477232T1 (de) | Neue substituierte arylhexadiensäuren und ester davon, die sich zur behandlung und prävention von diabetes, dyslipidämie und arteriosklerose eignen,pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung | |
| YU88602A (sh) | Stabilizovane farmaceutski efektivne smeše i farmaceutske formulacije koje ih sadrže |